Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

This publication has 46 references indexed in Scilit:

• Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT
  Aging Clinical and Experimental Research, 1998
• Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease
  Neuroscience Letters, 1998
• Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease
  Molecular and Chemical Neuropathology, 1996
• Elevated Alpha1-Antichymotrypsin Serum Levels in a Subset of Nondemented First-Degree Relatives of Alzheimer's Disease Patients
  Dementia and Geriatric Cognitive Disorders, 1995
• Inverse association of anti‐inflammatory treatments and Alzheimer's disease
  Neurology, 1994
• The acute phase response
  Immunology Today, 1994
• Modulation of systemic interleukin-6 induction by central interleukin-1
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1993
• Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
  FEBS Letters, 1991
• α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsin
  Neurobiology of Aging, 1990
• Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
  Cell, 1988